Poland highlights diabetes epidemic on World Health Day 2016

WHO

From left: Dr Paulina Karwowska, Head of WHO Country Office; Mr Piotr Warczyński, Undersecretary of State, Ministry of Health; Ms Marianna Bak, Chairperson, Warsaw Division of the Polish Diabetes Association; and Ms Milena Kruszewska, Director of the Press and Promotion Office and Spokesperson, Ministry of Health.

On World Health Day 2016, the WHO Country Office joined with the Ministry of Health of Poland and the Independent Public Children's Clinical Hospital in Warsaw to hold a briefing on diabetes. Mr Piotr Warczyński, Undersecretary of State, Ministry of Health; Dr Paulina Karwowska, Head of the WHO Country Office; and Ms Marianna Bak, Chairperson, Warsaw Division of the Polish Diabetes Association, were the main speakers at this media event.

On 13 April 2016, the WHO Country Office collaborated with the National Institute of Public Health – National Institute of Hygiene, the Chief Sanitary Inspectorate and the Institute of Mother and Child to organize a conference to raise awareness about diabetes. Professor Tomasz Zdrojewski (Medical University of Gdansk) presented data from a report on diabetes in Poland, while Dr Daniel Witkowski and Ms Milena Kuzaka from the Institute of Mother and Child discussed diabetes among children. Dr Karwowska also participated in the conference and introduced the first-ever WHO "Global report on diabetes", highlighting the main diabetes issues in Poland.

The country profile for Poland, released as part of the "Global report on diabetes", shows that diabetes accounts for 2% of all deaths in the country. It also provides a breakdown of the prevalence of diabetes and related risk factors. The overall diabetes prevalence in Poland stands at 9.5%. While the country profile illustrates the seriousness of the diabetes epidemic, it also offers an overview of the actions taken to address it, including a national study of risk factors for diabetes, in which measurements of blood glucose levels were conducted. Furthermore, the country profile indicates which medicines, basic technologies and procedures for treating diabetes are available in the public health sector.